The Valley Desk

ArticleJournal of managed care & specialty pharmacyPublished

Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Journal of managed care & specialty pharmacy
Published
Subject terms
Humans; Benzamides; Piperidines; Pyrazines; Pyrazoles; Pyrimidines; Adenine; Protein Kinase Inhibitors; Retrospective Studies; Cohort Studies; United States Department of Veterans Affairs; Aged
PubMed ID
41334748
PubMed Central ID
PMC12871522
Added to directory
Source checked

Report a correction or request removal